Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, February 1 '25)

Image
By G.M.

 


    Biochemistry (Mosc)

  1. KOROLEVA ON, Kuzmina NV, Tolstova AP, Dubrovin EV, et al
    Effect of C- and N-Terminal Polyhistidine Tags on Aggregation of Influenza A Virus Nuclear Export Protein.
    Biochemistry (Mosc). 2024;89:2238-2251.
    PubMed         Abstract available


    BMC Pediatr

  2. ZHANG P, Xin M, Bai Y, Ren X, et al
    Severe central nervous system injury in 9 children with COVID-19.
    BMC Pediatr. 2025;25:63.
    PubMed         Abstract available


    Epidemiol Infect

  3. BEDNARSKA NG, Smith S, Bardsley M, Loveridge P, et al
    Trends in general practitioner consultations for hand foot and mouth disease in England between 2017 and 2022.
    Epidemiol Infect. 2025;153:e22.
    PubMed         Abstract available


    J Virol

  4. KIRKPATRICK ROUBIDOUX E, Meliopoulos V, Livingston B, Brigleb PH, et al
    Intraductal infection with H5N1 clade 2.3.4.4b influenza virus.
    J Virol. 2025 Jan 31:e0192724. doi: 10.1128/jvi.01927.
    PubMed        

  5. SADLER HL, Rijal P, Tan TK, Townsend ARM, et al
    A locally administered single-cycle influenza vaccine expressing a non-fusogenic stabilized hemagglutinin stimulates strong T-cell and neutralizing antibody immunity.
    J Virol. 2025 Jan 27:e0033124. doi: 10.1128/jvi.00331.
    PubMed         Abstract available

  6. ZHAO B, Sun Z, Wang S, Shi Z, et al
    Structural basis of different neutralization capabilities of monoclonal antibodies against H7N9 virus.
    J Virol. 2025;99:e0140024.
    PubMed         Abstract available

  7. CAI Z, Ni W, Li W, Wu Z, et al
    SARS-CoV-2 S protein disrupts the formation of ISGF3 complex through conserved S2 subunit to antagonize type I interferon response.
    J Virol. 2024 Dec 19:e0151624. doi: 10.1128/jvi.01516.
    PubMed         Abstract available

  8. KAKIZAKI M, Hashimoto R, Nagata N, Yamamoto T, et al
    The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.
    J Virol. 2024 Nov 27:e0185324. doi: 10.1128/jvi.01853.
    PubMed         Abstract available

  9. BOLLAND W, Marechal I, Petiot C, Porrot F, et al
    SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts.
    J Virol. 2024 Nov 21:e0182324. doi: 10.1128/jvi.01823.
    PubMed         Abstract available


    JAMA

  10. BOCK A
    CDC Advises Expedited Influenza Subtyping in Hospitalized Patients to Help Identify Bird Flu Cases Sooner.
    JAMA. 2025 Jan 31. doi: 10.1001/jama.2025.0679.
    PubMed        


    Lancet

  11. MUMFORD L, Hogg R, Taylor A, Lanyon P, et al
    Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study.
    Lancet. 2025;405:314-328.
    PubMed         Abstract available


    PLoS Biol

  12. MEARS HV, Young GR, Sanderson T, Harvey R, et al
    Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion.
    PLoS Biol. 2025;23:e3002982.
    PubMed         Abstract available


    PLoS One

  13. KUMOSANI TA, Abbas AT, Basheer B, Hassan AM, et al
    Investigating Pb2 CAP-binding domain inhibitors from marine bacteria for targeting the influenza A H5N1.
    PLoS One. 2025;20:e0310836.
    PubMed         Abstract available

  14. TAT VY, Drelich AK, Huang P, Khanipov K, et al
    Characterizing temporal and global host innate immune responses against SARS-CoV-1 and -2 infection in pathologically relevant human lung epithelial cells.
    PLoS One. 2025;20:e0317921.
    PubMed         Abstract available

  15. BIDHENDI-YARANDI R, Biglarian A, Karlstad JL, Moe CF, et al
    Prevalence of depression, anxiety, stress, and suicide tendency among individual with long-COVID and determinants: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0312351.
    PubMed         Abstract available

  16. CLANCY P, Cassarino M
    Burnout and organisational stressors among healthcare staff working with adults with intellectual disabilities in Ireland.
    PLoS One. 2025;20:e0313767.
    PubMed         Abstract available

  17. HEGAZI MA, Sayed MH, Butt NS, Alahmadi TS, et al
    Navigating the shots: Parental willingness to immunize their children with COVID-19 vaccines in Saudi Arabia explored through a systematic review and meta-analysis.
    PLoS One. 2025;20:e0317983.
    PubMed         Abstract available

  18. YIN J, Xu J
    Intellectual capital, digital transformation and firms' financial performance: Evidence from ecological protection and environmental governance industry in China.
    PLoS One. 2025;20:e0316724.
    PubMed         Abstract available

  19. SUCHANEK P, Bucicova N
    The customer satisfaction model in the mobile telecommunications sector after Covid-19 pandemic.
    PLoS One. 2025;20:e0317093.
    PubMed         Abstract available

  20. MORBEY RA, Todkill D, Moura P, Tollinton L, et al
    Using machine learning to forecast peak health care service demand in real-time during the 2022-23 winter season: A pilot in England, UK.
    PLoS One. 2025;20:e0292829.
    PubMed         Abstract available

  21. LIU H, Zhao M, She C, Peng H, et al
    Classification of CT scan and X-ray dataset based on deep learning and particle swarm optimization.
    PLoS One. 2025;20:e0317450.
    PubMed         Abstract available

  22. GOPALAN N, Viswanathan VK, Srinivasalu VA, Arumugam S, et al
    Prediction of mortality and prioritisation to tertiary care using the 'OUR-ARCad' risk score gleaned from the second wave of COVID-19 pandemic-A retrospective cohort study from South India.
    PLoS One. 2025;20:e0312993.
    PubMed         Abstract available

  23. LEE I, Park H
    Moderating role of age in the relationship between ingroup range and intention to help during the COVID-19 pandemic.
    PLoS One. 2025;20:e0316316.
    PubMed         Abstract available

  24. SOLANKI G, Cleary S, Little F
    Impact of COVID-19 vaccination on hospitalization, hospital utilization and expenditure for COVID-19: A retrospective cohort analysis of a South African private health insured population.
    PLoS One. 2025;20:e0317686.
    PubMed         Abstract available

  25. MOHARRAM FA, Ibrahim RR, Mahgoub S, Abdel-Aziz MS, et al
    Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials.
    PLoS One. 2025;20:e0313616.
    PubMed         Abstract available

  26. BIOTTI F, Barker M, Carr L, Pickard H, et al
    The effects of the SARS-CoV-2 pandemic on self-reported interoception and mental health.
    PLoS One. 2025;20:e0314272.
    PubMed         Abstract available

  27. TOBITA Y, Diagne M, Bassama J, Ndong M, et al
    Exploring shifts in values among urban Senegalese: The impact of global crises on social and cultural norms.
    PLoS One. 2025;20:e0316162.
    PubMed         Abstract available

  28. AUDIGE A, Amstutz A, Schuurmans MM, Amico P, et al
    Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune function.
    PLoS One. 2025;20:e0317965.
    PubMed         Abstract available

  29. ROMANO ME, Buckley JP, Li X, Herbstman JB, et al
    Changes in urinary concentrations of contemporary and emerging chemicals in commerce during the COVID-19 pandemic: Insights from the Environmental influences on Child Health Outcomes (ECHO) program.
    PLoS One. 2025;20:e0317358.
    PubMed         Abstract available

  30. WEN Z, Wang T, Luo S, Liu Y, et al
    CT scan-derived pectoralis muscle parameters are closely associated with COVID-19 outcomes: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0316893.
    PubMed         Abstract available

  31. BOS I, Bosman L, van den Hoek R, van Waarden W, et al
    Comparison of observational methods to identify and characterize post-COVID syndrome in the Netherlands using electronic health records and questionnaires.
    PLoS One. 2025;20:e0318272.
    PubMed         Abstract available

  32. SANTACROCE LA, Appiah R, Sullivan MD, Spaniol J, et al
    Brief social presence improves delayed memory for online lecture content.
    PLoS One. 2025;20:e0318149.
    PubMed         Abstract available

  33. RO G, Lyngstad TM, Seppala E, Naerland Skodvin S, et al
    Estimating the trend of COVID-19 in Norway by combining multiple surveillance indicators.
    PLoS One. 2025;20:e0317105.
    PubMed         Abstract available

  34. RAZAI MS, Ussher M, Goldsmith L, Hargreaves S, et al
    Navigating vaccination in pregnancy: Qualitative study in 21 ethnically diverse pregnant women.
    PLoS One. 2025;20:e0310823.
    PubMed         Abstract available

  35. BONSAKSEN T, Price D, Lamph G, Kabelenga I, et al
    Sleep problems were unrelated to social media use in the late COVID-19 pandemic phase: A cross-national study.
    PLoS One. 2025;20:e0318507.
    PubMed         Abstract available

  36. WANG W, Zhu W, Hajagos J, Fochtmann L, et al
    Classification and Regression Trees analysis identifies patients at high risk for kidney function decline following hospitalization.
    PLoS One. 2025;20:e0317558.
    PubMed         Abstract available

  37. KYALA NJ, Mboya I, Shao E, Sakita F, et al
    Neutrophil-to-lymphocyte ratio as a prognostic indicator in COVID-19: Evidence from a northern tanzanian cohort.
    PLoS One. 2025;20:e0300231.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  38. NAKAMURA S, Tanimura Y, Nomura R, Suzuki H, et al
    Structure-guided engineering of a mutation-tolerant inhibitor peptide against variable SARS-CoV-2 spikes.
    Proc Natl Acad Sci U S A. 2025;122:e2413465122.
    PubMed         Abstract available

  39. YAN S, Schlick T
    Heterogeneous and multiple conformational transition pathways between pseudoknots of the SARS-CoV-2 frameshift element.
    Proc Natl Acad Sci U S A. 2025;122:e2417479122.
    PubMed         Abstract available


    Vaccine

  40. LE N, McMann TJ, Wenzel C, Li Z, et al
    COVID-19 pediatric vaccine Hesitancy: Themes and interactions with verified twitter accounts.
    Vaccine. 2025;47:126688.
    PubMed         Abstract available

  41. CASPERSEN IH, Skodvin SN, Blix K, Robertson AH, et al
    Post-COVID symptoms after SARS-CoV-2 omicron infection and the effect of booster vaccination: A population-based cohort study.
    Vaccine. 2025;47:126664.
    PubMed         Abstract available

  42. SHIELDS T, King KD, Cripps S, Edwards SA, et al
    Perspectives on vaccination among unvaccinated members of a Canadian indigenous population.
    Vaccine. 2025;47:126665.
    PubMed         Abstract available

  43. COROMINAS J, Garriga C, Prenafeta A, Moros A, et al
    Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial.
    Vaccine. 2025;47:126685.
    PubMed         Abstract available

  44. CLAESSENS T, Eagan RL, Hendrickx G, Van Damme P, et al
    Navigating vaccine confidence: A mixed methods study investigating healthcare providers' perspectives across four non-EU European regions.
    Vaccine. 2025;47:126694.
    PubMed         Abstract available

  45. KHAN A, Zhu Y, Babcock HM, Busse LW, et al
    COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019-2022.
    Vaccine. 2025 Jan 29:126806. doi: 10.1016/j.vaccine.2025.126806.
    PubMed         Abstract available

  46. KEMP M, Capriola A, Schauer S
    RSV immunization uptake among infants and pregnant persons - Wisconsin, October 1, 2023-March 31, 2024.
    Vaccine. 2025;47:126674.
    PubMed         Abstract available

  47. DUAN Y, Suo L, Li X, Bai C, et al
    Association between underlying conditions, multimorbidity, and COVID-19 vaccination status of adults aged >/=80 years old in Beijing, China.
    Vaccine. 2025;47:126677.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#USA, APHIS Confirms {Avian #Influenza #H5N1} #D11 #Genotype in Dairy #Cattle in #Nevada

By G.M.
On January 31, 2025, the USDA Animal and Plant Health Inspection Service (APHIS) National Veterinary Services Laboratories (NVSL) confirmed by whole genome sequence the first detection of highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b, genotype D1.1 in dairy cattle .  This confirmation was a result of State tracing and investigation, following an initial detection on silo testing under the USDA’s National Milk Testing Strategy (NMTS) in Nevada.  USDA APHIS continues to work with the Nevada Department of Agriculture by conducting additional on-farm investigation, testing, and gathering additional epidemiological information to better understand this detection and limit further disease spread.  This is the first detection of this virus genotype in dairy cattle (all previous detections in dairy cattle have been HPAI H5N1 clade 2.3.4.4b, genotype B3.13 ).  Genotype D1.1 represents the predominant genotype in the North American flyways this past fall an...
Post a Comment
Read more »

#USA, After #Birdflu Detected in Local #Cat, County #Health Officials Say #Pet Owners Should Contact Veterinarian When Their Pets are Sick

By G.M.
Redwood City — State veterinary and health officials have confirmed a case of H5N1 (bird flu) in a domestic stray cat in San Mateo County.  The infection, which is not related to the recent instance of bird flu in a backyard flock , was found in a stray cat in Half Moon Bay that had been taken in by a family .  When it showed symptoms, they took it to Peninsula Humane Society, whose veterinarians examined it and requested testing. Lab results confirmed H5N1.  It is not known how the cat was infected and it was euthanized due to its condition. Cats may be exposed to bird flu by consuming infected bird , being in environments contaminated with the virus and consuming unpasteurized milk from infected cows or raw food. Inside domestic animals, such as cats and dogs, that go outside are also at risk of infection.​​​​​​​ According to the Centers for Disease Control and Prevention, the risk of cats spreading H5N1 to people is extremely low, though it is possible for cats to spre...
Post a Comment
Read more »

#USA, Novel #Influenza A #H5N1 Virus: One Pediatric Case in #California {FluView}

By G.M.
 {Excerpt} One confirmed human infection with influenza A(H5) virus was reported to CDC this week. To date, human-to-human transmission of influenza A(H5) virus has not been identified in the United States. This case was reported by the California Department of Public Health and occurred in a child less than 18 years old with no known contact with influenza A(H5N1) virus-infected animals or humans . The investigation into the source of infection for this case is ongoing , and no human-to-human transmission has been identified. A specimen from the individual was tested at a public health laboratory using the CDC influenza A(H5) assay before being sent to CDC for further testing. The specimen was positive for influenza A(H5) virus using diagnostic RT-PCR at CDC. Additional analysis including genetic sequencing is underway. In response to this detection, additional case investigation and contact monitoring are being conducted by public health officials in California. There have now be...
Post a Comment
Read more »